MCID: EPL070
MIFTS: 51

Epilepsy, Progressive Myoclonic 2b malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Metabolic diseases

Aliases & Classifications for Epilepsy, Progressive Myoclonic 2b

About this section
Sources:
49OMIM, 65UMLS, 11diseasecard, 10Disease Ontology, 45NIH Rare Diseases, 47Novoseek, 12DISEASES, 51Orphanet, 67UniProtKB/Swiss-Prot, 36MeSH, 24GTR, 42NCIt, 59SNOMED-CT, 28ICD10 via Orphanet, 37MESH via Orphanet, 66UMLS via Orphanet, 34MedGen, 61The Human Phenotype Ontology
See all MalaCards sources

Aliases & Descriptions for Epilepsy, Progressive Myoclonic 2b:

Name: Epilepsy, Progressive Myoclonic 2b 49 65
Lafora Disease 10 45 47 12 51 67 36 65
Myoclonic Epilepsy of Lafora 10 45 67
Lafora's Disease 10 67 24
Epm2 45 51 67
Epilepsy, Progressive Myoclonic 2a 49 11
Progressive Myoclonic Epilepsy 2b 67 24
Melf 45 67
Progressive Myoclonic Epilepsy Lafora Type 67
Lafora Progressive Myoclonic Epilepsy 10
Progressive Myoclonic Epilepsy Type 2 51
 
Progressive Myoclonus Epilepsy Type 2 51
Epilepsy, Progressive Myoclonic 2 67
Progressive Myoclonic Epilepsy 2a 67
Epilepsy Progressive Myoclonic 2 45
Progressive Myoclonic Epilepsy 2 67
Lafora Body Disorder 45
Pme Type 2 51
Epm2a 67
Epm2b 67
Ld 67

Characteristics:

Orphanet epidemiological data:

51
lafora disease:
Inheritance: Autosomal recessive; Prevalence: 1-9/1000000 (France); Age of onset: Childhood

HPO:

61
epilepsy, progressive myoclonic 2b:
Onset and clinical course: rapidly progressive
Inheritance: heterogeneous, autosomal recessive inheritance


Classifications:



External Ids:

OMIM49 254780
Disease Ontology10 DOID:3534
MeSH36 D020192
NCIt42 C84804
Orphanet51 501
SNOMED-CT59 230425004
ICD10 via Orphanet28 G40.3
MESH via Orphanet37 D020192
UMLS via Orphanet66 C0751783
UMLS65 C0751783, C1850764

Summaries for Epilepsy, Progressive Myoclonic 2b

About this section
OMIM:49 The Lafora type of progressive myoclonic epilepsy is an autosomal recessive disorder characterized by insidious onset... (254780) more...

MalaCards based summary: Epilepsy, Progressive Myoclonic 2b, also known as lafora disease, is related to epm2a-related lafora disease and nhlrc1-related lafora disease, and has symptoms including visual auras, bilateral convulsive seizures and visual hallucinations. An important gene associated with Epilepsy, Progressive Myoclonic 2b is EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin)), and among its related pathways are Glycogen storage diseases and Diseases of metabolism. Affiliated tissues include brain, heart and liver, and related mouse phenotypes are muscle and cellular.

NIH Rare Diseases:45 Lafora disease is an inherited, severe form of progressive myoclonus epilepsy. the condition most commonly begins with epileptic seizures in late childhood or adolescence. other signs and symptoms include difficulty walking, muscle spasms (myoclonus) and dementia. affected people also experience rapid cognitive deterioration that begins around the same time as the seizures. the condition is often fatal within 10 years of onset. most cases are caused by changes (mutations) in either the epm2a gene or the nhlrc1 gene and are inherited in an autosomal recessive manner. treatment is based on the signs and symptoms present in each person. last updated: 9/29/2015

UniProtKB/Swiss-Prot:67 Epilepsy, progressive myoclonic 2: An autosomal recessive and severe form of adolescent-onset progressive epilepsy. Typically, as seizures increase in frequency, cognitive function declines towards dementia, and affected individuals die usually within 10 years after onset. EPM2 occurs worldwide, but it is particularly common in the mediterranean countries of southern Europe and northern Africa, in southern India and in the Middle East. At the cellular level, it is characterized by accumulation of starch-like polyglucosans called Lafora bodies (LBs) that are most abundant in organs with the highest glucose metabolism: brain, heart, liver and skeletal muscle. Among other conditions involving polyglucosans, EPM2 is unique in that the inclusions are in neuronal dendrites but not axons and the forming polyglucosan fibrils are associated with the endoplasmic reticulum.

Related Diseases for Epilepsy, Progressive Myoclonic 2b

About this section

Diseases in the Myoclonic Epilepsy of Infancy family:

Epilepsy, Myoclonic, Familial Adult, 5 Epilepsy, Myoclonic, Familial Adult, 2
Epilepsy, Progressive Myoclonic 5 Epilepsy, Juvenile Myoclonic 5
epilepsy, progressive myoclonic 2b Myoclonic Epilepsy, Juvenile 1
Epilepsy, Progressive Myoclonic 7 Epilepsy, Progressive Myoclonic 1b
Myoclonic Epilepsy, Infantile, Familial Epilepsy, Progressive Myoclonic 6
Epilepsy, Progressive Myoclonic, 9 Epilepsy, Progressive Myoclonic, 8
Epilepsy, Progressive Myoclonic 1a Epilepsy Progressive Myoclonic Type 3
Cacnb4-Related Juvenile Myoclonic Epilepsy Clcn2-Related Juvenile Myoclonic Epilepsy
Efhc1-Related Juvenile Myoclonic Epilepsy Ejm2-Related Juvenile Myoclonic Epilepsy
Ejm3-Related Juvenile Myoclonic Epilepsy Ejm4-Related Juvenile Myoclonic Epilepsy
Gabra1-Related Juvenile Myoclonic Epilepsy Gabrd-Related Juvenile Myoclonic Epilepsy
Scn1a-Related Severe Myoclonic Epilepsy in Infancy Benign Adult Familial Myoclonic Epilepsy
Epilepsy, Progressive Myoclonic 10

Diseases related to Epilepsy, Progressive Myoclonic 2b via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 140)
idRelated DiseaseScoreTop Affiliating Genes
1epm2a-related lafora disease12.3
2nhlrc1-related lafora disease12.3
3progressive myoclonus epilepsy, lafora type11.6
4early myoclonic encephalopathy11.5
5myoclonus11.5
6epilepsy syndrome11.5
7progressive myoclonus epilepsy11.5
8unverricht-lundborg syndrome11.4
9atypical polypoid adenomyoma11.4
10myoclonus epilepsy11.4
11loeys-dietz syndrome11.4
12loeys-dietz syndrome 110.8
13shprintzen-goldberg syndrome10.4
14legionaire disease10.4
15melanoma10.4
16epilepsy, progressive myoclonic 1a10.3
17sleep apnea10.3
18obstructive sleep apnea10.3
19corneal dystrophy10.3
20prostatitis10.3
21loeys-dietz syndrome 510.3
22lactate dehydrogenase deficiency10.3
23botulism10.3
24uterine fibroid10.3
25prothrombin-related thrombophilia10.3EPM2A, NHLRC1
26pancreatitis10.2
27cystic lymphangioma10.2CSTB, EPM2A
28lung cancer10.2
29breast cancer10.2
30leukemia10.2
31lymphoma10.2
32heart disease10.2
33pneumothorax10.2
34glioma10.2
35endotheliitis10.2
36maternally-inherited spastic paraplegia10.2EPM2A, NHLRC1
37prostate cancer10.1
38von hippel-lindau syndrome10.1
39beckwith-wiedemann syndrome10.1
40bipolar disorder10.1
41neurofibromatosis10.1
42meningitis10.1
43myoclonus epilepsy partial seizure10.1CSTB, EPM2A, NHLRC1
44myopathy - thyrotoxic10.1CSTB, EPM2A, NHLRC1
45rheumatoid arthritis10.0
46neuroblastoma10.0
47colorectal cancer10.0
48myocardial infarction10.0
49hiv-110.0
50cystinuria10.0

Graphical network of the top 20 diseases related to Epilepsy, Progressive Myoclonic 2b:



Diseases related to epilepsy, progressive myoclonic 2b

Symptoms for Epilepsy, Progressive Myoclonic 2b

About this section

Symptoms by clinical synopsis from OMIM:

254780

Clinical features from OMIM:

254780

HPO human phenotypes related to Epilepsy, Progressive Myoclonic 2b:

(show all 16)
id Description Frequency HPO Source Accession
1 visual auras HP:0011165
2 bilateral convulsive seizures HP:0007334
3 visual hallucinations HP:0002367
4 progressive neurologic deterioration HP:0002344
5 apraxia HP:0002186
6 generalized myoclonic seizures HP:0002123
7 absence seizures HP:0002121
8 generalized tonic-clonic seizures HP:0002069
9 abnormality of metabolism/homeostasis HP:0001939
10 hepatic failure HP:0001399
11 myoclonus HP:0001336
12 gait disturbance HP:0001288
13 cutaneous photosensitivity HP:0000992
14 dementia HP:0000726
15 psychosis HP:0000709
16 visual loss HP:0000572

Drugs & Therapeutics for Epilepsy, Progressive Myoclonic 2b

About this section

Drugs for Epilepsy, Progressive Myoclonic 2b (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 36)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Inulinapproved, nutraceuticalPhase 4959005-80-524763
Synonyms:
(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethy
189444-25-5
887747-94-6
AC1L2NNM
AI3-19506
CID24763
DB00638
 
EINECS 232-684-3
INULIN
Inulin USP 27
Inulin [BAN]
Inulin and sodium chloride
Inulin from Jerusalem artichokes
LS-186416
LS-187349
2Soy BeanNutraceuticalPhase 4455
3ColaNutraceuticalPhase 41768
4
PerphenazineapprovedPhase 38358-39-94748
Synonyms:
.gamma.-[4-(.beta.-Hydroxyethyl)piperazin-1-yl]propyl-2-chlorophenothiazine
1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina
1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina [Italian]
1-(2-Hydroxyethyl)-4-(3-(2-chloro-10-phenothiazinyl)propyl)piperazine
1-(2-Hydroxyethyl)-4-[3-(2-chloro-10-phenothiazinyl)propyl]piperazine
1-Piperazineethanol, 4-[3-(2-chlorophenothiazin-10-yl)propyl]-, trihydrochloride
2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol
2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol
2-Chloro-10-(3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine
2-Chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine
2-Chloro-10-3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl phenothiazine
2-Chloro-10-3-[1-(2-hydroxyethyl)-4-piperazinyl]propyl phenothiazine
2-Chloro-10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazine
2-[4-[3-(2-Chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine
2-{4-[3-(2-Chloro-phenothiazin-10-yl)-propyl]-piperazin-1-yl}-ethanol
2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol
4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol
4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol
4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol
4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol
58-39-9
AB00052390
AC-12196
AC1L1IVB
AI3-50151
AKOS000664046
Apo-Perphenazine
BAS 00139131
BIDD:GT0150
BPBio1_000188
BRD-K10995081-001-05-5
BSPBio_000170
BSPBio_002376
C07427
C21H26ClN3OS
CAS-58-39-9
CHEBI:8028
CHEMBL567
CID4748
CPD000058180
Chlorperphenazine
Chlorpiprazine
D00503
D010546
DB00850
Decentan
DivK1c_000880
EINECS 200-381-5
EU-0072164
EU-0100930
Emesinal
Etaperazin
Etaperazine
Ethaperazine
Etrafon-A
Etrafon-Forte
F-Mon
F-mon
Fentazin
HMS1568I12
HMS1922M14
HMS2093M15
HMS502L22
HSDB 3379
I06-1508
IDI1_000880
KBio1_000880
KBio2_002090
KBio2_004658
KBio2_007226
 
KBio3_001596
KBioGR_001445
KBioSS_002090
L000919
LS-112185
Lopac-P-6402
Lopac0_000930
MLS000069637
MLS001146929
MolPort-001-727-942
NCGC00015826-01
NCGC00015826-02
NCGC00015826-03
NCGC00015826-06
NCGC00015826-10
NCGC00024092-03
NCGC00024092-04
NCGC00024092-05
NCGC00024092-06
NINDS_000880
NSC 150866
NSC150866
Oprea1_603835
P 6402
P6402_SIGMA
PZC
Perfenazina
Perfenazina [INN-Spanish]
Perfenazina [Italian]
Perfenazine
Perphenan
Perphenazin
Perphenazine
Perphenazine (JP15/USP/INN)
Perphenazine [INN:BAN:JAN]
Perphenazine [Trilafon]
Perphenazine enanthate
Perphenazine heptanoate
Perphenazine maleate
Perphenazinum
Perphenazinum [INN-Latin]
Perphénazine
Prestwick0_000125
Prestwick1_000125
Prestwick2_000125
Prestwick3_000125
Prestwick_536
SAM002264637
SCH-3940
SMR000058180
SPBio_001603
SPBio_002109
SPECTRUM1503934
SR-01000000137-4
STK019818
STOCK1S-21551
Sch 3940
Spectrum2_001602
Spectrum3_000758
Spectrum4_000843
Spectrum5_001493
Spectrum_001610
Thilatazin
Tranquisan
Trifaron
Trilafon
Trilifan
Triphenot
UNII-FTA7XXY4EZ
WLN: T C666 BN ISJ EG B3- AT6N DNTJ D2Q
gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine
nchembio873-comp26
perphenazine
5
Olanzapineapproved, investigationalPhase 3379132539-06-14585
Synonyms:
132539-06-1
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10 H -thieno[2,3- b ] [1,5]benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine
AC-665
AC1L1IHS
AKOS000282888
ALKS-7921
BIDD:GT0332
BIDD:PXR0138
Bio-0169
C07322
C076029
C17H20N4S
CHEBI:7735
CHEMBL715
CID4585
CPD000466345
D00454
DB00334
Eli Lilly brand of olanzapine
HMS2051H05
HMS2089M04
HMS2093I04
I06-0784
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3
Jsp001969
KS-1090
L000455
L005958
LS-152313
LY 170053
LY-170052
LY-170053
 
Lanzac
Lilly brand of olanzapine
MLS000759457
MLS001165781
MLS001195646
MLS001424057
Midax
MolPort-002-885-845
MolPort-003-666-569
MolPort-005-977-341
NCGC00096077-01
NCGC00096077-03
NCGC00096077-04
Olansek
Olanzapin
Olanzapina
Olanzapine
Olanzapine (JAN/USAN/INN)
Olanzapine (OLA)
Olanzapine [USAN:INN]
Olanzapine pamoate
Olanzapinum
S2493_Selleck
SAM001246652
SMR000466345
SPECTRUM1505024
STK634338
Symbyax
TL8000772
UNII-N7U69T4SZR
Zalasta
Zydis
Zyprexa
Zyprexa (TN)
Zyprexa Intramuscular
Zyprexa Velotab
Zyprexa Zydis
olanzapina
olanzapine
olanzapinum
6
MethotrimeprazineapprovedPhase 3660-99-172287
Synonyms:
(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine
(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine
2-Methoxytrimeprazine
 
Levomepromazina
Levomepromazine
Levomepromazinum
Methoprazine
Methotrimeprazine
7
PimozideapprovedPhase 3112062-78-416362
Synonyms:
1-(1-(4,4-Bis(p-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone
1-(4,4-Bis(p-fluorophenyl)butyl)-4-(2-oxo-1-benzimidazolinyl)piperidine
1-[1-[4,4-Bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H- benzimidazol-2-one
1-[1-[4,4-Bis(p-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone
1-[1-[4,4-bis(4-Fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one
1-[4,4-Bis(p-fluorophenyl)butyl]-4-(2-oxo-1-benzimidazolinyl)piperidine
1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one
2062-78-4
3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one
5-24-02-00367 (Beilstein Handbook Reference)
AB00052215
AC1L27SR
AC1Q4M09
AC1Q4NM9
ASTA Medica Brand of Pimozide
Antalon
BCBcMAP01_000043
BIDD:GT0435
BPBio1_000304
BRD-K01292756-001-06-0
BRN 0729089
BSPBio_000276
BSPBio_001439
BSPBio_002941
C07566
C28H29F2N3O
CAS-2062-78-4
CCRIS 9172
CHEBI:8212
CHEMBL1423
CID16362
D00560
D010868
DB01100
DivK1c_000386
EINECS 218-171-7
EU-0100946
HMS1568N18
HMS1791H21
HMS1921H19
HMS1989H21
HMS2089C11
HMS2092F09
HMS501D08
Halomonth
IDI1_000386
Janssen Brand of Pimozide
KBio1_000386
KBio2_000925
KBio2_003493
KBio2_006061
KBio3_002441
KBioGR_000720
KBioSS_000925
L000494
LS-33236
Lopac-P-1793
Lopac0_000946
MLS000028410
 
MLS001077311
MLS002702058
McN-JR 6238
McN-JR-6238
MolPort-001-736-597
NCGC00015802-01
NCGC00015802-02
NCGC00015802-04
NCGC00015802-15
NCGC00016601-01
NCGC00022282-03
NCGC00024888-01
NCGC00024888-02
NCGC00024888-03
NCGC00024888-04
NCGC00024888-05
NCGC00024888-06
NCGC00024888-07
NCIMech_000356
NINDS_000386
NSC 170984
NSC170984
Neoperidole
Opiran
Orap
Orap (TN)
Orap forte
P 1793
P1793_SIGMA
Pharmascience Brand of Pimozide
Pimozida
Pimozida [INN-Spanish]
Pimozide
Pimozide (JAN/USP/INN)
Pimozide [USAN:INN:BAN:JAN]
Pimozidum
Pimozidum [INN-Latin]
Prestwick0_000308
Prestwick1_000308
Prestwick2_000308
Prestwick3_000308
Prestwick_395
Primozida
Primozida [INN-Spanish]
R 6238
R-6238
R6238
SMP1_000241
SMR000058385
SPBio_001211
SPBio_002495
SPECTRUM1501134
Spectrum2_001026
Spectrum3_001451
Spectrum4_000420
Spectrum5_001308
Spectrum_000445
Tocris-0937
UNII-1HIZ4DL86F
WLN: T56 BMVNJ D- DT6NTJ A3YR DF&R DF
pimozida
pimozide
8
SulpirideapprovedPhase 32315676-16-15355
Synonyms:
( inverted question mark)-Sulpiride
(+-)-Sulpiride
(+/-)-Sulpiride
(?)-Sulpiride
(RS)-(+/-)-sulpiride
15676-16-1
23672-07-3
5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide
5-22-08-00105 (Beilstein Handbook Reference)
AC-12181
AC1L1K62
AKOS004912732
Abilit
Aiglonyl
Alimoral
Allphar Brand of Sulpiride
Almirall Brand of Sulpiride
Areu Brand of Sulpiride
Arminol
BPBio1_000233
BPBio1_000463
BPBio1_001255
BRD-A55272860-001-03-9
BRD-A55272860-001-04-7
BRN 0494008
BSPBio_000211
Bio-0717
Biomol-NT_000037
Biomol-NT_000162
C15H23N3O4S
CCRIS 4248
CHEMBL26
CID5355
Calmoflorine
Centrum Brand of Sulpiride
Championyl
Coolspan
D01226
D013469
DB00391
Darleton
Deponerton
Desisulpid
Desitin Brand of Sulpiride
Desmenat
Digton
DivK1c_000278
Dobren
Dogmatil
Dogmatyl
Dogmatyl (TN)
Dolmatil
Dolorgiet Brand of Sulpiride
Dresent
EINECS 239-753-7
EU-0001755
EU-0101050
Eglonil
Eglonyl
Ekilid
Enimon
Equilid
Erempharma Brand of Sulpiride
Eusulpid
Fardalan
Fidelan
Fumouzer Brand of Sulpiride
Guastil
HMS1568K13
HMS500N20
Hennig Brand of Sulpiride
Hexal Brand of Sulpiride
Hoechst Brand of Sulpiride
Hormosan Brand of Sulpiride
I06-0054
IDI1_000278
Isnamide
KBio1_000278
Krewel Brand of Sulpiride
Kylistro
L000579
LS-20058
LS-20059
Lebopride
Levobren
Levopraid
Levosulpirida
Levosulpirida [INN-Spanish]
 
Levosulpiride
Levosulpiride [INN]
Levosulpiridum
Levosulpiridum [INN-Latin]
Lisopiride
Lopac0_001050
MLS000069434
MLS001306443
Magnetic resonance imaging sulpiride
Mariastel
Meresa
Miradol
Mirbanil
Misulvan
MolPort-002-070-475
N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide
N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide
N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
NCGC00015966-04
NCGC00015966-08
NCGC00024852-02
NCGC00024852-03
NCGC00024852-04
NCGC00024852-05
NINDS_000278
Neogama
Norestran
Normum
Nufarol
Omiryl
Omperan
Oprea1_602476
Ozoderpin
Pharmacia Brand of Sulpiride
Pontiride
Prestwick0_000056
Prestwick1_000056
Prestwick2_000056
Prestwick3_000056
Prestwick_431
Psicocen
Psicofarma Brand of Sulpiride
Pyrikappl
Pyrkappl
R. D. 1403
R.D. 1403
RD 1403
RV-12309
Restful
Rosemont Brand of Sulpiride
S 8010
S-(-)-Sulpiride
S8010_SIGMA
SMR000038923
SPBio_002132
STK368596
Sanofi Synthelabo Brand of Sulpiride
Sanofi-Synthelabo Brand of Sulpiride
Sernevin
Splotin
Spyfarma Brand of Sulpiride
Stamonevrol
Sulp
Sulperide
Sulpirid
Sulpirida
Sulpirida [INN-Spanish]
Sulpiride (JP15/USAN/INN)
Sulpiride [USAN:INN:BAN:JAN]
Sulpiridum
Sulpiridum [INN-Latin]
Sulpitil
Sulpivert
Sulpor
Sulpride
Sulpyrid
Suprium
Sursumid
Synedil
Tepavil
Uriach Brand of Sulpiride
Valirem
Vertigo Meresa
Vertigo-Meresa
Zemorcon
nchembio873-comp17
sulpiride
vertigo neogama
vertigo-neogama
9
ZiprasidoneapprovedPhase 3140146939-27-760854
Synonyms:
138982-67-9 (hydrochloride monohydrate)
146939-27-7
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
6-chloro-5-[2-[4-(7-thia-8-azabicyclo[4.3.0]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one
AC1L1U27
Ambap122883-93-6
BIDD:GT0042
C07568
C21H21ClN4OS
CHEBI:10119
CHEMBL708
CID60854
CP 88059
CP 88059-01
CP-88,059
CP-88,059-01
CP-88,059-1
CP-88059-1
CPD000466328
D08687
DB00246
 
Geodon
Geodon Oral
I14-0766
L000659
LS-83744
MLS000759435
MolPort-003-850-885
SAM001246607
SMR000466328
TL8000889
UNII-6UKA5VEJ6X
Zeldox
Zipradon
Zipradon (TN)
Ziprasidona
Ziprasidone
Ziprasidone (INN)
Ziprasidone Hydrochloride
Ziprasidone [INN:BAN]
Ziprasidone hydrochloride
Ziprasidone mesylate trihydrate
Ziprasidonum
ziprasidona
ziprasidonum
ziprazidone
10
TrifluoperazineapprovedPhase 35117-89-55566
Synonyms:
10-(3-(4-Methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)phenothiazine
10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-10H-phenothiazine
10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-phenothiazine
10-(gamma-(N'-Methylpiperazino)propyl)-2-trifluoromethylphenothiazine
10-[3-(4-METHYL-PIPERAZIN-1-YL)-PROPYL]-2-TRIFLUOROMETHYL-10H-PHENOTHIAZINE
10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine
10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine
10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-phenothiazine
10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine
10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine dihydrochloride
117-89-5
2-Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine
AB00053558
AC1L1KMT
AC1Q3ZYE
AKOS001487920
Apo-Trifluoperazine
Apo-trifluoperazine (TN)
BIDD:PXR0132
BPBio1_000338
BPBio1_001345
BRD-K89732114-001-02-6
BRD-K89732114-001-03-4
BRD-K89732114-300-05-5
BSPBio_000306
BSPBio_001190
BSPBio_002928
Bio1_000458
Bio1_000947
Bio1_001436
Bio2_000435
Bio2_000915
Biomol-NT_000060
C07168
C21H24F3N3S
CAS-440-17-5
CCRIS 6994
CHEBI:101325
CHEBI:45951
CHEMBL422
CID5566
Calmazine
D08636
DB00831
DB08616
DivK1c_000843
EINECS 204-219-4
Eskazine
Eskazinyl
Fluoperazine
Flurazine
HMS1362L11
HMS1792L11
HMS1990L11
HMS2089J11
HSDB 3195
IDI1_000843
IDI1_002190
Jatroneural
KBio1_000843
KBio2_000530
KBio2_001148
KBio2_002431
KBio2_003098
KBio2_003716
KBio2_004999
KBio2_005666
KBio2_006284
KBio2_007567
KBio3_000959
KBio3_000960
KBio3_002148
KBio3_002910
KBioGR_000530
KBioGR_000835
KBioGR_002431
KBioSS_000530
KBioSS_001148
KBioSS_002437
L001075
LS-105595
Lopac-T-8516
Lopac0_001232
MLS002702821
Modalina
MolPort-001-727-956
 
NCGC00013226
NCGC00013226-02
NCGC00013226-03
NCGC00013226-04
NCGC00013226-12
NCGC00024251-03
NCGC00024251-04
NCGC00024251-05
NCGC00024251-06
NCGC00024251-07
NCI17474
NCI60_001427
NCI60_004087
NCIStruc1_001127
NCIStruc2_001093
NINDS_000843
NSC 17474
NSC 46061
NSC-17474
NSC17474
NSC46061
Novo-Trifluzine
PDSP1_001300
PDSP2_001284
PMS Trifluoperazine
Prestwick0_000313
Prestwick1_000313
Prestwick2_000313
Prestwick3_000313
QTL1_000085
RP 7623
SKF 5019
SMR001566649
SPBio_000755
SPBio_002525
SR-01000003020-6
STK182873
STOCK1S-51401
Spectrum2_000828
Spectrum3_001374
Spectrum4_000368
Spectrum5_001553
Spectrum_000668
Stelazine
Stelazine (*Dihydrochloride*)
Stelazine Concentrate
Stellazine
Synklor
TFP
Terfluzine
Trazine
Trifluoperazin
Trifluoperazina
Trifluoperazina [INN-Spanish]
Trifluoperazina [Italian]
Trifluoperazine
Trifluoperazine (INN)
Trifluoperazine Dihydrochloride
Trifluoperazine HCl
Trifluoperazine Hydrochloride
Trifluoperazine [INN:BAN]
Trifluoperazine dihydrochloride
Trifluoperazinum
Trifluoperazinum [INN-Latin]
Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine
Trifluoromethylperazine
Trifluoroperazine
Trifluoroperazine Dihydrochloride
Trifluoroperazine Hydrochloride
Trifluoroperazine dihydrochloride
Trifluperazine
Triflurin
Trifluroperizine
Triftazin
Triftazine
Triperazine
Tripfluoperazine Hydrochloride
Triphtazin
Triphtazine
Triphthasine
Triphthazine
Triphthazine Dihydrochloride
Tryptazine
Tryptazine Dihydrochloride
UNII-214IZI85K3
cMAP_000048
nchembio873-comp70
trifluoperazine
11
DroperidolapprovedPhase 321548-73-23168
Synonyms:
1-(1-(3-(P-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone
1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone
1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-2H-benzimidazol-2-one
1-(1-(4-(P-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone
1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone
1-1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone
1-[1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone
1-[1-[4-(p-F
1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone
1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one
1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one
1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
2-Benzimidazolinone, 1-[1-[3-(p-fluorobenz
3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one
5-24-02-00388 (Beilstein Handbook Reference)
548-73-2
AC-3537
AC1L1FBQ
BPBio1_000505
BRD-K97158071-001-05-8
BRN 0579168
BSPBio_000459
BSPBio_003132
C22H22FN3O2
CAS-548-73-2
CCRIS 9070
CHEBI:252751
CHEBI:4717
CHEMBL1108
CID3168
CPD000058855
D00308
D004329
D1414_SIGMA
DB00450
DHBP
Dehidrobenzperidol
Dehydrobenzoperidol
Dehydrobenzperidol
Deidrobenzperidolo
Dihidrobenzperidol
DivK1c_000103
Dridol
Droleptan
Droleptan (TN)
Droperidol
Droperidol (JP15/USP/INN)
Droperidol [USAN:INN:BAN:JAN]
Droperidolo
Droperidolo [DCIT]
Droperidolum
Droperidolum [INN-Latin]
Dropéridol
EINECS 208-957-8
HMS1569G21
HMS1921B03
HMS2051L06
HMS2092O16
HMS500F05
HS-0065
HSDB 3320
Halkan
I14-2728
IDI1_000103
INAPSINE (TN)
 
Ina.psi.n
Ina.psi.ne
Inappin
Inapsin
Inapsine
Innovan
Innovar-vet
Ino.psi.n
Inopsin
Inoval
Janssen Brand of Droperidol
KBio1_000103
KBio2_001700
KBio2_004268
KBio2_006836
KBio3_002352
KBioGR_000674
KBioSS_001700
Kern Brand of Droperidol
L001006
LS-33253
Leptanal
Leptofen
MLS000028671
MLS000758203
MLS001148120
MLS002153445
McN-JR 4749
McN-JR-4749
NCGC00016504-01
NCGC00016504-02
NCGC00094884-01
NCGC00094884-02
NINDS_000103
NSC 169874
NSC169874
Prestwick0_000360
Prestwick1_000360
Prestwick2_000360
Prestwick3_000360
Prestwick_705
Properidol
R 4749
R-4749
R4749
SAM001247013
SMR000058855
SPBio_001372
SPBio_002380
SPECTRUM1501002
Sintodril
Sintosian
Spectrum2_001386
Spectrum3_001426
Spectrum4_000407
Spectrum5_001305
Spectrum_001220
Taylor Brand of Droperidol
Thalamanol
Thalamonal
UNII-O9U0F09D5X
Vetkalm
WLN: T56 BMVNJ D3- DT6N CUTJ A3VR DF
ZINC19796080
component of Innovar
droperidol
luorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone
12
Risperidoneapproved, investigationalPhase 3477106266-06-25073
Synonyms:
106266-06-2
3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydro-pyrido[
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
AB00514010
AC-1306
AC1L1JJU
BIDD:GT0262
BRD-K53857191-001-04-5
BRN 4891881
Belivon
Bio-0092
Buspirone
C23H27FN4O2
CAS-106266-06-2
CHEBI:8871
CHEMBL85
CID5073
CPD000466323
Consta, Risperdal
D00426
D018967
DB00734
EU-0101074
HMS1571M19
HMS2051H07
HMS2089C22
HSDB 7580
I01-1156
Jsp000573
KS-1106
L000510
LS-134196
Lopac-R-118
MLS000759429
MLS001165758
MLS001424081
MolPort-002-885-858
NCGC00015883-01
 
NCGC00015883-02
NCGC00015883-03
NCGC00094352-01
NCGC00094352-02
NCGC00094352-03
NCGC00179257-01
Prestwick0_001029
Prestwick1_001029
R 62 766
R 64 766, Risperdal, Risperidone
R 64,766
R 64766
R-118
R-64,766
R-64-766
R-64766
R64,766
R64766
Rispen
Risperdal
Risperdal (TN)
Risperdal Consta
Risperdal M-Tab
Risperdal M-tab
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Risperidone (JAN/USAN/INN)
Risperidone (RIS)
Risperidone M-tab
Risperidone [USAN:BAN:INN]
Risperidone, placebo
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
S1615_Selleck
SAM001246595
SMR000466323
SPBio_003078
STK646402
Sequinan
Spiron
TL8000230
UNII-L6UH7ZF8HC
risperdone
risperidone
13
HaloperidolapprovedPhase 313652-86-83559
Synonyms:
1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine
4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone
4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone
4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one
5-21-02-00377 (Beilstein Handbook Reference)
52-86-8
AB00052008
AC-19691
AC1L1G7K
AC1Q77Z0
AKOS000280660
ALDO
Aldo
Aloperidin
Aloperidol
Aloperidolo
Aloperidolo [DCIT]
Aloperidolo [Italian]
Aloperidon
Apo-Haloperidol
BIDD:GT0128
BPBio1_000144
BPBio1_001231
BRD-K67783091-001-04-8
BRD-K67783091-001-05-5
BRN 0331267
BSPBio_000130
BSPBio_002096
Bio-0705
Biomol-NT_000035
Bioperidolo
Brotopon
C01814
C21H23ClFNO2
CAS-52-86-8
CCRIS 1630
CHEBI:5613
CHEMBL54
CID3559
D00136
D006220
DB00502
DivK1c_000654
Dozic
Dozix
EINECS 200-155-6
EU-0100583
Einalon S
Eukystol
Fortunan
Galoperidol
H 1512
H0912
H1512_SIGMA
HMS1568G12
HMS1920D03
HMS2089M15
HMS2091J09
HMS502A16
HSDB 3093
Haldol
Haldol Decanoate
Haldol La
Haldol Solutab
Halidol
Halojust
Halol
Halopal
Haloperido
Haloperidol
Haloperidol (JP15/USP)
Haloperidol (JP15/USP/INN)
Haloperidol Decanoate
Haloperidol Intensol
Haloperidol Lactate
Haloperidol [USAN:INN:BAN:JAN]
Haloperidolum
Haloperidolum [INN-Latin]
Halopidol
Halopoidol
Halosten
I14-13404
I14-14165
 
IDI1_000654
KBio1_000654
KBio2_001341
KBio2_002390
KBio2_003909
KBio2_004958
KBio2_006477
KBio2_007526
KBio3_001316
KBio3_002869
KBioGR_000980
KBioGR_002390
KBioSS_001341
KBioSS_002395
Keselan
L000288
LS-48311
Lealgin Compositum
Lealgin compositum
Linton
Lopac-H-1512
Lopac0_000583
MLS000028450
MLS001146904
McN-JR-1625
Mixidol
MolPort-000-883-311
NCGC00015500-01
NCGC00015500-02
NCGC00015500-06
NCGC00015500-14
NCGC00016234-01
NCGC00023875-02
NCGC00023875-04
NCGC00023875-05
NCGC00023875-06
NCGC00023875-07
NCGC00023875-08
NCGC00023875-09
NINDS_000654
NSC 170973
NSC 615296
NSC170973
NSC615296
Novo-Peridol
Oprea1_509923
Pekuces
Peluces
Peridol
Pernox
Pms Haloperidol
Prestwick0_000115
Prestwick1_000115
Prestwick2_000115
Prestwick3_000115
Prestwick_250
Probes1_000255
Probes2_000296
QTL1_000042
R 1625
R-1625
S1920_Selleck
SMR000058303
SPBio_001236
SPBio_002069
SPECTRUM1500325
Serenace
Serenase
Serenelfi
Sernas
Sernel
Sigaperidol
Spectrum2_001268
Spectrum3_000448
Spectrum4_000570
Spectrum5_000788
Spectrum_000861
Tocris-0931
UNII-J6292F8L3D
Ulcolind
Uliolind
Vesalium
WLN: T6NTJ A3VR DF& DQ DR DG
cMAP_000037
gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone
haloperidol
14
Aripiprazoleapproved, investigationalPhase 3342129722-12-960795
Synonyms:
129722-12-9
24-29-3
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril
7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one
AC-1554
AC1L1TXZ
AC1Q3T38
ALKS-9070
Abilify
Abilify (TN)
Abilify DISCMELT
Abilify Discmelt
Abilify Maintena
Abilitat
Aripiprazol
Aripiprazole
Aripiprazole (JAN/USAN/INN)
Aripiprazole [USAN]
Aripiprazolum
Aripirazole
Arpizol
Asprito|
BMS-337039
Bio-0004
Bristol-Myers Squibb brand of aripiprazole
C094645
C12564
C23H27Cl2N3O2
CHEBI:31236
CHEMBL1112
CID60795
 
CPD000466383
D01164
DB01238
Discmelt
FT-0082572
HMS2051I18
HMS2089M20
HMS2093F22
HSDB 7320
KS-1030
L001339
LS-142666
MLS000759517
MLS001165779
MLS001195621
MLS001424078
MolPort-002-885-808
MolPort-003-844-657
NCGC00159510-02
NCGC00159510-03
OPC 31
OPC-14597
OPC-31
Opc 14597
Otsuka brand of aripiprazole
Pripiprazole
S06-0010
SAM001246750
SMR000466383
STK625160
TL8000707
TL80090184
UNII-82VFR53I78
aripiprazol
aripiprazole
aripiprazolum
||OPC 14597
15
ClozapineapprovedPhase 31135786-21-02818
Synonyms:
3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine
5786-21-0
8-Chloro-11-(4-methyl)-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b,e)(1,4)diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]-diazepine
8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
AC-280
AC1L1EJE
AC1Q3OPZ
AC1Q3ZWP
AKOS005064444
AR-1I2412
Asaleptin
BRD-K37289225-001-09-1
BRN 0764984
Bio1_000436
Bio1_000925
Bio1_001414
Bio2_000310
Bio2_000790
C 6305
C06924
C18H19ClN4
C6305_SIGMA
CAS-5786-21-0
CCRIS 9171
CHEBI:3766
CHEMBL42
CID2818
CLOZARIL
CPD000058365
Chlorpromazine
Clorazil
Clozapin
Clozapina
Clozapina [INN-Spanish]
Clozapine
Clozapine (JAN/USP/INN)
Clozapine [USAN:INN:BAN]
Clozapinum
Clozapinum [INN-Latin]
Clozaril
Clozaril (TN)
D00283
D003024
DB00363
DivK1c_000343
EINECS 227-313-7
EU-0100276
FT-0082373
Fazaclo
Fazaclo ODT
HF-1854
HF1854
HMS1361P12
HMS1569E21
HMS1791P12
HMS1921C16
HMS1989P12
HMS2089L13
HMS2092I16
HMS501B05
 
HSDB 6478
I06-0047
InChI=1/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3
Iprox
KBio1_000343
KBio2_000310
KBio2_000599
KBio2_002878
KBio2_003167
KBio2_005446
KBio2_005735
KBio3_000619
KBio3_000620
KBio3_002979
KBioGR_000310
KBioGR_001336
KBioSS_000310
KBioSS_000599
KS-1166
L000195
L013417
LEX-123
LS-60881
LX 100-129
Leponex
Lepotex
Lopac-C-6305
MLS000028472
MLS001077282
MolPort-001-728-041
NCGC00015254-01
NCGC00015254-02
NCGC00015254-03
NCGC00015254-07
NCGC00015254-17
NCGC00022902-02
NCGC00022902-04
NCGC00022902-05
NCGC00022902-06
NCGC00022902-07
NCGC00022902-08
NCGC00022902-09
NCGC00022902-10
NCGC00022902-11
NCGC00022902-13
NINDS_000343
Prestwick0_000350
Prestwick1_000350
Prestwick_693
S2459_Selleck
SAM002548976
SMR000058365
SPBio_000798
SPBio_002340
SPECTRUM1500685
Spectrum2_000919
Spectrum3_001828
Spectrum4_000898
Spectrum_000139
Tocris-0444
UNII-J60AR2IKIC
Versacloz
W-801
clozapine
clozapine(tautomer)
16
DopamineapprovedPhase 3308462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
17
AsenapineapprovedPhase 35385650-56-2, 65576-45-63001386, 11954293
Synonyms:
135882-95-0
1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrole, 5-chloro-2,3,3a,12b-tetrahydro-2-met
5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz(2,3-6,7)oxepino(4,5-c)pyrrole
65576-45-6
AC1L4SHR
Asenapi
Asenapine
Asenapine Maleate
Asenapine [INN:BAN]
CHEMBL504548
 
CID163091
EINECS 265-829-4
I14-8821
Org 5222
Org-5222
PDSP1_001600
PDSP2_001584
Saphris
UNII-JKZ19V908O
[13C,2H3]-Asenipine
trans-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz(2,3:6,7)oxepino(4,5-c)pyrrole
18
ChlorpromazineapprovedPhase 31350-53-32726
Synonyms:
10-(3-Dimethylaminopropyl)-2-chlorophenothiazine
10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, radical ion(1+)
2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine
2-Chloro-10-[3-(dimethylamino)propyl]phenothiazine
2-Chloropromazine
2-Cloro-10 (3-dimetilaminopropil)fenotiazina
2-Cloro-10 (3-dimetilaminopropil)fenotiazina [Italian]
2-chloro-10-(3-(dimethylamino)propyl)-phenothiazine
2-chloro-N,N-dimethyl-10H-Phenothiazine-10-propanamine
2601A
3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-1-propanamine
3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine
3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine
3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine
3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine
3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine
34468-21-8
4560 R.P
4560 R.P.
4560 Rp hydrochloride
50-53-3
AB00051943
AC1L1EBT
AKOS001490972
Aminasine
Aminazin
Aminazine
Ampliactil
Amplicitil
Amplictil
BAS 00010434
BC 135
BPBio1_000273
BPBio1_001181
BSPBio_000247
BSPBio_002011
Bio1_000457
Bio1_000946
Bio1_001435
Biomol-NT_000020
C06906
C17H19ClN2S
CAS-69-09-0
CCRIS 3711
CHEBI:3647
CHEMBL71
CID2726
CPZ
Chlor-PZ
Chlor-Promanyl
Chlordelazine
Chlorderazin
Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine
Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine [French]
Chloropromazine
Chlorpromados
Chlorpromanyl
Chlorpromanyl (discontinued)
Chlorpromanyl-20
Chlorpromanyl-40
Chlorpromazin
Chlorpromazine
Chlorpromazine (USP/INN)
Chlorpromazine Hydrochloride
Chlorpromazine Hydrochloride Intensol
Chlorpromazine Tannate
Chlorpromazine [USAN:INN:BAN]
Chlorpromazine hydrochloride
Chlorpromazinum
Chlorpromazinum [INN-Latin]
Clorpromazina
Clorpromazina [INN-Spanish]
Clorpromazina [Italian]
Contomin
Cromedazine
D00270
DB00477
DivK1c_000624
EINECS 200-045-8
Elmarin
Esmind
Fenactil
Fenaktyl
Fraction AB
HL 5746
HMS1920M03
HMS2089C12
HMS2091E06
HMS501P06
 
HSDB 3033
I14-6226
IDI1_000624
JHICC02042
KBio1_000624
KBio2_000622
KBio2_002312
KBio2_003190
KBio2_004880
KBio2_005758
KBio2_007448
KBio3_001231
KBio3_002792
KBioGR_000806
KBioGR_002312
KBioSS_000622
KBioSS_002314
L000182
LS-105361
Largactil
Largactil Liquid
Largactil Oral Drops
Largactilothiazine
Largactyl
Lopac-C-8138
Lopac0_000249
Megaphen
MolPort-001-727-953
N-(3-Dimethylaminopropyl)-3-chlorophenothiazine
NCGC00015273-01
NCGC00015273-02
NCGC00015273-03
NCGC00015273-14
NCGC00024409-04
NCGC00024409-05
NCGC00024409-06
NCGC00024409-07
NCGC00024409-08
NINDS_000624
NSC 167745
NSC167745
NSC17479
Novo-Chlorpromazine
Novomazina
Oprea1_110255
Phenactyl
Phenathyl
Phenothiazine hydrochloride
Plegomasine
Plegomazin
Prazilpromactil
Prestwick0_000064
Prestwick1_000064
Prestwick2_000064
Prestwick3_000064
Proma
Promactil
Promazil
Propaphen
Propaphenin
Prozil
Psychozine
QTL1_000021
SKF 2601-A
SKF 2601A
SKF-2601
SPBio_001111
SPBio_002168
SPECTRUM1500184
SR-01000000012-5
STK182870
STOCK1S-46588
Sanopron
Spectrum2_001156
Spectrum3_000346
Spectrum4_000283
Spectrum5_000717
Spectrum_000142
Thorazine
Thorazine (TN)
Thorazine Spansule
Thorazine Suppositories
Thorazine hydrochloride
Torazina
UNII-U42B7VYA4P
WLN: T C666 BN ISJ B3N1&1 EG
Wintermin
Z80
[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine
cMAP_000017
chlorpromazine
19Quetiapine FumaratePhase 3403111974-72-2
20sultopridePhase 346
21Tiapride HydrochloridePhase 35
22AntiemeticsPhase 33213
23Antipsychotic AgentsPhase 32130
24Tranquilizing AgentsPhase 33597
25Psychotropic DrugsPhase 35501
26Central Nervous System DepressantsPhase 310016
27Gastrointestinal AgentsPhase 36401
28Flupenthixol decanoatePhase 314
29Dopamine AgentsPhase 33084
30Dopamine AntagonistsPhase 3927
31Haloperidol decanoatePhase 3136
32Neurotransmitter AgentsPhase 314795
33Peripheral Nervous System AgentsPhase 318510
34ClopenthixolPhase 36
35Insulin, Globin Zinc4278
36insulin4278

Interventional clinical trials:

idNameStatusNCT IDPhase
1Dietary Fiber Mixture in Constipated Pediatric PatientsCompletedNCT01333787Phase 4
2Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective PsychosisRecruitingNCT01765829Phase 3
3Ketogenic Diet in Lafora DiseaseCompletedNCT00007124

Search NIH Clinical Center for Epilepsy, Progressive Myoclonic 2b


Cochrane evidence based reviews: lafora disease

Genetic Tests for Epilepsy, Progressive Myoclonic 2b

About this section

Anatomical Context for Epilepsy, Progressive Myoclonic 2b

About this section

MalaCards organs/tissues related to Epilepsy, Progressive Myoclonic 2b:

33
Brain, Heart, Liver, Skeletal muscle

Animal Models for Epilepsy, Progressive Myoclonic 2b or affiliated genes

About this section

MGI Mouse Phenotypes related to Epilepsy, Progressive Myoclonic 2b:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.2CSTB, DUSP6, EPM2A, GBE1, NHLRC1, PARK2
2MP:00053847.0CLN3, CSTB, DUSP4, DUSP6, EPM2A, GBE1

Publications for Epilepsy, Progressive Myoclonic 2b

About this section

Variations for Epilepsy, Progressive Myoclonic 2b

About this section

UniProtKB/Swiss-Prot genetic disease variations for Epilepsy, Progressive Myoclonic 2b:

67 (show all 41)
id Symbol AA change Variation ID SNP ID
1EPM2Ap.Ser25ProVAR_019465
2EPM2Ap.Glu28LysVAR_019466
3EPM2Ap.Trp32GlyVAR_019467
4EPM2Ap.Phe84LeuVAR_019469
5EPM2Ap.Phe88LeuVAR_019470
6EPM2Ap.Arg91ProVAR_019471
7EPM2Ap.Arg108CysVAR_019472
8EPM2Ap.Arg171HisVAR_019474
9EPM2Ap.Thr187AlaVAR_019475
10EPM2Ap.Thr194IleVAR_019476
11EPM2Ap.Gly240SerVAR_019477
12EPM2Ap.Gly279SerVAR_019478
13EPM2Ap.Gln293LeuVAR_019479
14EPM2Ap.Tyr294AsnVAR_019480
15EPM2Ap.Pro301LeuVAR_019481
16EPM2Ap.Lys140AsnVAR_046383
17EPM2Ap.Asn148TyrVAR_046384
18EPM2Ap.Glu210LysVAR_046385
19EPM2Ap.Leu310TrpVAR_046386
20NHLRC1p.Cys26SerVAR_019482rs28940575
21NHLRC1p.Phe33SerVAR_019483
22NHLRC1p.Pro69AlaVAR_019484rs28940576
23NHLRC1p.Leu87ProVAR_019485
24NHLRC1p.Asp146AsnVAR_019487
25NHLRC1p.Gln302ProVAR_019488
26NHLRC1p.Ser22ArgVAR_046387
27NHLRC1p.Glu67GlnVAR_046388
28NHLRC1p.Cys68TyrVAR_046389
29NHLRC1p.Leu126ProVAR_046390
30NHLRC1p.Ile153MetVAR_046391
31NHLRC1p.Cys160ArgVAR_046392rs200595273
32NHLRC1p.Ile198AsnVAR_046393
33NHLRC1p.Trp219ArgVAR_046394
34NHLRC1p.Asp233AlaVAR_046395
35NHLRC1p.Asp245AsnVAR_046396
36NHLRC1p.Arg253LysVAR_046397
37NHLRC1p.Pro264HisVAR_046398
38NHLRC1p.Leu279ProVAR_046399
39NHLRC1p.Asp308AlaVAR_046401
40NHLRC1p.Cys46TyrVAR_070793
41NHLRC1p.Leu261ProVAR_070794

Clinvar genetic disease variations for Epilepsy, Progressive Myoclonic 2b:

5 (show all 13)
id Gene Variation Type Significance SNP ID Assembly Location
1NHLRC1NM_198586.2(NHLRC1): c.436G> A (p.Asp146Asn)single nucleotide variantPathogenicrs769301934GRCh37Chr 6, 18122402: 18122402
2NHLRC1NM_198586.2(NHLRC1): c.664G> T (p.Glu222Ter)single nucleotide variantPathogenicrs794726964GRCh37Chr 6, 18122174: 18122174
3NHLRC1NM_198586.2(NHLRC1): c.76T> A (p.Cys26Ser)single nucleotide variantPathogenicrs28940575GRCh37Chr 6, 18122762: 18122762
4NHLRC1NM_198586.2(NHLRC1): c.205C> G (p.Pro69Ala)single nucleotide variantPathogenicrs28940576GRCh37Chr 6, 18122633: 18122633
5NHLRC1NM_198586.2(NHLRC1): c.468_469delAG (p.Gly158Argfs)deletionPathogenicrs587776542GRCh37Chr 6, 18122369: 18122370
6NHLRC1NM_198586.2(NHLRC1): c.593T> A (p.Ile198Asn)single nucleotide variantPathogenicrs121917876GRCh37Chr 6, 18122245: 18122245
7EPM2ANM_005670.3(EPM2A): c.721C> T (p.Arg241Ter)single nucleotide variantPathogenicrs104893950GRCh37Chr 6, 145948827: 145948827
8EPM2ANM_005670.3(EPM2A): c.835G> A (p.Gly279Ser)single nucleotide variantPathogenicrs137852917GRCh37Chr 6, 145948713: 145948713
9EPM2ANM_005670.3(EPM2A): c.322C> T (p.Arg108Cys)single nucleotide variantPathogenicrs137852915GRCh37Chr 6, 146007412: 146007412
10EPM2ANM_005670.3(EPM2A): c.335dupA (p.Tyr112Terfs)duplicationPathogenicrs587776553GRCh37Chr 6, 146007399: 146007399
11EPM2ANM_005670.3(EPM2A): c.512G> A (p.Arg171His)single nucleotide variantPathogenicrs137852916GRCh37Chr 6, 145956587: 145956587
12EPM2ANM_005670.3(EPM2A): c.950dupT (p.Gln319Profs)duplicationPathogenicrs587776554GRCh37Chr 6, 145948598: 145948598
13NM_005670.3(EPM2A): c.94T> G (p.Trp32Gly)single nucleotide variantPathogenicrs104893955GRCh37Chr 6, 146056541: 146056541

Expression for genes affiliated with Epilepsy, Progressive Myoclonic 2b

About this section
Search GEO for disease gene expression data for Epilepsy, Progressive Myoclonic 2b.

Pathways for genes affiliated with Epilepsy, Progressive Myoclonic 2b

About this section

Pathways related to Epilepsy, Progressive Myoclonic 2b according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.4EPM2A, NHLRC1, PPP1R3C
2
Show member pathways
9.4EPM2A, NHLRC1, PPP1R3C
3
Show member pathways
9.2DUSP4, DUSP6
4
Show member pathways
9.1EPM2A, GBE1, NHLRC1, PPP1R3C
5
Show member pathways
9.1EPM2A, GBE1, NHLRC1, PPP1R3C

GO Terms for genes affiliated with Epilepsy, Progressive Myoclonic 2b

About this section

Biological processes related to Epilepsy, Progressive Myoclonic 2b according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1macroautophagyGO:001623610.1CLN3, PARK2
2negative regulation of protein phosphorylationGO:000193310.0DUSP6, PARK2
3glycogen biosynthetic processGO:00059789.8EPM2A, NHLRC1, PPP1R3C
4carbohydrate metabolic processGO:00059759.7GBE1, NHLRC1, PPP1R3C
5toll-like receptor TLR1:TLR2 signaling pathwayGO:00381239.5DUSP4, DUSP6
6stress-activated MAPK cascadeGO:00514039.5DUSP4, DUSP6
7toll-like receptor 9 signaling pathwayGO:00341629.4DUSP4, DUSP6
8glucose metabolic processGO:00060069.4EPM2A, GBE1, NHLRC1, PPP1R3C
9toll-like receptor 5 signaling pathwayGO:00341469.3DUSP4, DUSP6
10inactivation of MAPK activityGO:00001889.2DUSP4, DUSP6
11toll-like receptor 2 signaling pathwayGO:00341349.1DUSP4, DUSP6
12dephosphorylationGO:00163118.3DUSP13, DUSP19, DUSP4, DUSP6
13protein dephosphorylationGO:00064707.7CDKN3, DUSP19, DUSP4, DUSP6, EPM2A
14peptidyl-tyrosine dephosphorylationGO:00353357.4CDKN3, DUSP13, DUSP19, DUSP4, DUSP6, EPM2A

Molecular functions related to Epilepsy, Progressive Myoclonic 2b according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MAP kinase tyrosine/serine/threonine phosphatase activityGO:00170179.8DUSP4, DUSP6
2phosphatase activityGO:00167919.0CDKN3, DUSP13, DUSP19
3protein bindingGO:00055157.8CDKN3, CSTB, DUSP13, DUSP19, EPM2A, NFU1

Sources for Epilepsy, Progressive Myoclonic 2b

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet